{"id":5369,"date":"2021-11-03T14:06:00","date_gmt":"2021-11-03T14:06:00","guid":{"rendered":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/onderzoeksupdate-november-2021\/"},"modified":"2024-09-23T11:22:28","modified_gmt":"2024-09-23T11:22:28","slug":"onderzoeksupdate-november-2021","status":"publish","type":"post","link":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/onderzoeksupdate-november-2021\/","title":{"rendered":"Onderzoeksupdate: stamceltherapie kan het verschil maken"},"content":{"rendered":"

We bespreken graag de belangrijkste ontwikkelingen op het gebied van internationaal wetenschappelijk onderzoek naar type 1 diabetes (T1D). Nieuwe inzichten, vooruitgang in lopende onderzoeken en grote doorbraken: alles komt aan bod. Deze keer gaan we in op het jaarlijkse Europese symposium over diabetes (EASD) en de resultaten van stamceltherapie van Vertex.<\/strong><\/strong><\/p>\n

European association for the study of Diabetes (EASD)<\/h2>\n

Van 27 september tot 1 oktober vond het jaarlijkse symposium over diabetes EASD plaats. Verschillende vooraanstaand wetenschappers van over de hele wereld presenteerden hier hun onderzoeken. Meer dan veertig van deze studies worden of werden door Breakthrough T1D gefinancierd. Onderwerpen die aan bod kwamen tijdens dit symposium waren immuunsysteem modulerende therapie\u00ebn, hypoglykemie, het functioneren (of niet functioneren) van de b\u00e8tacellen en de kunstmatige alvleesklier.

Meer lezen over het symposium? Dat kan <\/em>hier<\/em><\/a><\/p>\n<\/em>\n

(Engelstalig).<\/em><\/p>\n

Vertex deelt resultaten van stamceltherapie<\/h2>\n

Vertex is in februari gestart met klinische proeven van VX-880. Dit is een therapie waarbij insulineproducerende b\u00e8tacellen uit stamcellen, in het lichaam worden geplaatst. In oktober maakte Vertex de resultaten bekend van de eerste persoon die meedoet aan deze proef. Ondanks dat deze proef pas negentig dagen bezig is en ze pas halverwege de therapie zijn, worden al veelbelovende resultaten gevonden.
<\/p>\n

Zo gebruikt de eerste proefpersoon gemiddeld 91% minder insuline op een dag. Daarnaast is zijn of haar HbA1c verbeterd, van 8,6% naar 7,2%. Ook had deze persoon geen ernstige hypo’s meer.
<\/p>\n

Bij de proeven wordt gebruik gemaakt van medicijnen die het immuunsysteem onderdrukken om afstoting te voorkomen. Om deze therapie te laten werken voor meer mensen met type 1 diabetes moeten de cellen kunnen werken zonder, of met zo min mogelijk, van deze medicatie. Na deze klinische proeven wil Vertex op dit gebied volgende stappen zetten om dichter bij de genezing van T1D te komen.

Meer lezen over dit onderzoek? Dat kan <\/em>hier<\/em><\/a><\/p>\n<\/em>\n

(Engelstalig). <\/em><\/p>\n

\n

Steun wetenschappelijk onderzoek<\/h2>\n

Type 1 diabetes (T1D) de wereld uit helpen: dat is de missie van Breakthrough T1D. Om dit te bereiken werken wij wereldwijd samen voor het beste wetenschappelijk onderzoek. Jouw steun maakt dat een oplossing voor T1D dichterbij komt. Samen maken we van type \u00e9\u00e9n, type g\u00e9\u00e9n!<\/p>\n \n

\n
Maak een wereld zonder T1D mogelijk<\/a><\/div>\n <\/div>\n <\/div>","protected":false,"raw":""},"excerpt":{"rendered":"

We bespreken graag de belangrijkste ontwikkelingen op het gebied van internationaal wetenschappelijk onderzoek naar type 1 diabetes (T1D). Nieuwe inzichten, vooruitgang in lopende onderzoeken en grote doorbraken: alles komt aan bod. Deze keer gaan we in op het jaarlijkse Europese symposium over diabetes (EASD) en de resultaten van stamceltherapie van Vertex. European association for the […]<\/p>\n","protected":false},"author":1,"featured_media":5370,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[184],"tags":[],"class_list":["post-5369","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-archief"],"yoast_head":"\nOnderzoeksupdate: stamceltherapie kan het verschil maken - Breakthrough T1D<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/onderzoeksupdate-november-2021\/\" \/>\n<meta property=\"og:locale\" content=\"nl_NL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Onderzoeksupdate: stamceltherapie kan het verschil maken - Breakthrough T1D\" \/>\n<meta property=\"og:description\" content=\"We bespreken graag de belangrijkste ontwikkelingen op het gebied van internationaal wetenschappelijk onderzoek naar type 1 diabetes (T1D). Nieuwe inzichten, vooruitgang in lopende onderzoeken en grote doorbraken: alles komt aan bod. Deze keer gaan we in op het jaarlijkse Europese symposium over diabetes (EASD) en de resultaten van stamceltherapie van Vertex. European association for the […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/onderzoeksupdate-november-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"Breakthrough T1D\" \/>\n<meta property=\"article:published_time\" content=\"2021-11-03T14:06:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-09-23T11:22:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2021\/11\/Science-591404013-3-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1707\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"ylt-admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Geschreven door\" \/>\n\t<meta name=\"twitter:data1\" content=\"ylt-admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Geschatte leestijd\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/onderzoeksupdate-november-2021\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/onderzoeksupdate-november-2021\/\"},\"author\":{\"name\":\"ylt-admin\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/c141fde9814deb17e9eb392bdb6619a6\"},\"headline\":\"Onderzoeksupdate: stamceltherapie kan het verschil maken\",\"datePublished\":\"2021-11-03T14:06:00+00:00\",\"dateModified\":\"2024-09-23T11:22:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/onderzoeksupdate-november-2021\/\"},\"wordCount\":368,\"publisher\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#organization\"},\"image\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/onderzoeksupdate-november-2021\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2021\/11\/Science-591404013-3-scaled.jpg\",\"articleSection\":[\"Archief\"],\"inLanguage\":\"nl-NL\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/onderzoeksupdate-november-2021\/\",\"url\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/onderzoeksupdate-november-2021\/\",\"name\":\"Onderzoeksupdate: stamceltherapie kan het verschil maken - Breakthrough T1D\",\"isPartOf\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/onderzoeksupdate-november-2021\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/onderzoeksupdate-november-2021\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2021\/11\/Science-591404013-3-scaled.jpg\",\"datePublished\":\"2021-11-03T14:06:00+00:00\",\"dateModified\":\"2024-09-23T11:22:28+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/onderzoeksupdate-november-2021\/#breadcrumb\"},\"inLanguage\":\"nl-NL\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/onderzoeksupdate-november-2021\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/onderzoeksupdate-november-2021\/#primaryimage\",\"url\":\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2021\/11\/Science-591404013-3-scaled.jpg\",\"contentUrl\":\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2021\/11\/Science-591404013-3-scaled.jpg\",\"width\":2560,\"height\":1707},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/onderzoeksupdate-november-2021\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/breakthrought1d.eu\/nl\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Onderzoeksupdate: stamceltherapie kan het verschil maken\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#website\",\"url\":\"https:\/\/breakthrought1d.eu\/nl\/\",\"name\":\"Breakthrough T1D\",\"description\":\"Wij zetten ons in voor een toekomst zonder T1D\",\"publisher\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/breakthrought1d.eu\/nl\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"nl-NL\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#organization\",\"name\":\"Breakthrough T1D\",\"url\":\"https:\/\/breakthrought1d.eu\/nl\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/11\/BTlogo.png\",\"contentUrl\":\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/11\/BTlogo.png\",\"width\":330,\"height\":141,\"caption\":\"Breakthrough T1D\"},\"image\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/c141fde9814deb17e9eb392bdb6619a6\",\"name\":\"ylt-admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/67a3317a8082bc0f586c2e46f82a1617530cf674f2027a1a7d60fdff63a2c3e8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/67a3317a8082bc0f586c2e46f82a1617530cf674f2027a1a7d60fdff63a2c3e8?s=96&d=mm&r=g\",\"caption\":\"ylt-admin\"},\"sameAs\":[\"https:\/\/87.250.144.92\"],\"url\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/author\/ylt-admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Onderzoeksupdate: stamceltherapie kan het verschil maken - Breakthrough T1D","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/onderzoeksupdate-november-2021\/","og_locale":"nl_NL","og_type":"article","og_title":"Onderzoeksupdate: stamceltherapie kan het verschil maken - Breakthrough T1D","og_description":"We bespreken graag de belangrijkste ontwikkelingen op het gebied van internationaal wetenschappelijk onderzoek naar type 1 diabetes (T1D). Nieuwe inzichten, vooruitgang in lopende onderzoeken en grote doorbraken: alles komt aan bod. Deze keer gaan we in op het jaarlijkse Europese symposium over diabetes (EASD) en de resultaten van stamceltherapie van Vertex. European association for the […]","og_url":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/onderzoeksupdate-november-2021\/","og_site_name":"Breakthrough T1D","article_published_time":"2021-11-03T14:06:00+00:00","article_modified_time":"2024-09-23T11:22:28+00:00","og_image":[{"width":2560,"height":1707,"url":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2021\/11\/Science-591404013-3-scaled.jpg","type":"image\/jpeg"}],"author":"ylt-admin","twitter_card":"summary_large_image","twitter_misc":{"Geschreven door":"ylt-admin","Geschatte leestijd":"2 minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/onderzoeksupdate-november-2021\/#article","isPartOf":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/onderzoeksupdate-november-2021\/"},"author":{"name":"ylt-admin","@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/c141fde9814deb17e9eb392bdb6619a6"},"headline":"Onderzoeksupdate: stamceltherapie kan het verschil maken","datePublished":"2021-11-03T14:06:00+00:00","dateModified":"2024-09-23T11:22:28+00:00","mainEntityOfPage":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/onderzoeksupdate-november-2021\/"},"wordCount":368,"publisher":{"@id":"https:\/\/breakthrought1d.eu\/nl\/#organization"},"image":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/onderzoeksupdate-november-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2021\/11\/Science-591404013-3-scaled.jpg","articleSection":["Archief"],"inLanguage":"nl-NL"},{"@type":"WebPage","@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/onderzoeksupdate-november-2021\/","url":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/onderzoeksupdate-november-2021\/","name":"Onderzoeksupdate: stamceltherapie kan het verschil maken - Breakthrough T1D","isPartOf":{"@id":"https:\/\/breakthrought1d.eu\/nl\/#website"},"primaryImageOfPage":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/onderzoeksupdate-november-2021\/#primaryimage"},"image":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/onderzoeksupdate-november-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2021\/11\/Science-591404013-3-scaled.jpg","datePublished":"2021-11-03T14:06:00+00:00","dateModified":"2024-09-23T11:22:28+00:00","breadcrumb":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/onderzoeksupdate-november-2021\/#breadcrumb"},"inLanguage":"nl-NL","potentialAction":[{"@type":"ReadAction","target":["https:\/\/breakthrought1d.eu\/nl\/nieuws\/onderzoeksupdate-november-2021\/"]}]},{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/onderzoeksupdate-november-2021\/#primaryimage","url":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2021\/11\/Science-591404013-3-scaled.jpg","contentUrl":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2021\/11\/Science-591404013-3-scaled.jpg","width":2560,"height":1707},{"@type":"BreadcrumbList","@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/onderzoeksupdate-november-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/breakthrought1d.eu\/nl\/"},{"@type":"ListItem","position":2,"name":"Onderzoeksupdate: stamceltherapie kan het verschil maken"}]},{"@type":"WebSite","@id":"https:\/\/breakthrought1d.eu\/nl\/#website","url":"https:\/\/breakthrought1d.eu\/nl\/","name":"Breakthrough T1D","description":"Wij zetten ons in voor een toekomst zonder T1D","publisher":{"@id":"https:\/\/breakthrought1d.eu\/nl\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/breakthrought1d.eu\/nl\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"nl-NL"},{"@type":"Organization","@id":"https:\/\/breakthrought1d.eu\/nl\/#organization","name":"Breakthrough T1D","url":"https:\/\/breakthrought1d.eu\/nl\/","logo":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/logo\/image\/","url":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/11\/BTlogo.png","contentUrl":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/11\/BTlogo.png","width":330,"height":141,"caption":"Breakthrough T1D"},"image":{"@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/c141fde9814deb17e9eb392bdb6619a6","name":"ylt-admin","image":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/67a3317a8082bc0f586c2e46f82a1617530cf674f2027a1a7d60fdff63a2c3e8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/67a3317a8082bc0f586c2e46f82a1617530cf674f2027a1a7d60fdff63a2c3e8?s=96&d=mm&r=g","caption":"ylt-admin"},"sameAs":["https:\/\/87.250.144.92"],"url":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/author\/ylt-admin\/"}]}},"_links":{"self":[{"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/posts\/5369","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/comments?post=5369"}],"version-history":[{"count":2,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/posts\/5369\/revisions"}],"predecessor-version":[{"id":8849,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/posts\/5369\/revisions\/8849"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/media\/5370"}],"wp:attachment":[{"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/media?parent=5369"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/categories?post=5369"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/tags?post=5369"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}